Cargando…
Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar ma...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468080/ https://www.ncbi.nlm.nih.gov/pubmed/32952579 |
_version_ | 1783578140221636608 |
---|---|
author | KARIMZADEH, Parvaneh GHOFRANI, Mohammad NASIRI, Shahram |
author_facet | KARIMZADEH, Parvaneh GHOFRANI, Mohammad NASIRI, Shahram |
author_sort | KARIMZADEH, Parvaneh |
collection | PubMed |
description | Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar manifestations leads to delayed diagnosis of neurometabolic disorders. A number of neurometabolic disorders have known treatments; however, to prevent long-term complications the key factors are early diagnosis and treatment. Although a large number of neurometabolic diseases have no treatment or cure, the correct and on-time diagnosis before death is important for parents to have plans for prenatal diagnosis. Different diagnostic procedures could be offered to parents, enzymatic procedures, and determining metabolites in plasma, urine, and CSF, and molecular genetic diagnosis. Molecular genetic diagnostic procedures are expensive and could not be offered to all parents. Therefore, we aimed to design algorithms to diagnose neurometabolic disorders according to some frequent and characteristic signs and symptoms. By designing these algorithms and using them properly, we could offer diagnostic enzymatic panels. These enzymatic panels are inexpensive; thereby reducing the financial burden on the parents. Also, having an early diagnosis according to these panels could lead to offering more accurate and less expensive molecular genetic tests. |
format | Online Article Text |
id | pubmed-7468080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Shahid Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-74680802020-10-01 Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms KARIMZADEH, Parvaneh GHOFRANI, Mohammad NASIRI, Shahram Iran J Child Neurol Review Article Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar manifestations leads to delayed diagnosis of neurometabolic disorders. A number of neurometabolic disorders have known treatments; however, to prevent long-term complications the key factors are early diagnosis and treatment. Although a large number of neurometabolic diseases have no treatment or cure, the correct and on-time diagnosis before death is important for parents to have plans for prenatal diagnosis. Different diagnostic procedures could be offered to parents, enzymatic procedures, and determining metabolites in plasma, urine, and CSF, and molecular genetic diagnosis. Molecular genetic diagnostic procedures are expensive and could not be offered to all parents. Therefore, we aimed to design algorithms to diagnose neurometabolic disorders according to some frequent and characteristic signs and symptoms. By designing these algorithms and using them properly, we could offer diagnostic enzymatic panels. These enzymatic panels are inexpensive; thereby reducing the financial burden on the parents. Also, having an early diagnosis according to these panels could lead to offering more accurate and less expensive molecular genetic tests. Shahid Beheshti University of Medical Sciences 2020 /pmc/articles/PMC7468080/ /pubmed/32952579 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article KARIMZADEH, Parvaneh GHOFRANI, Mohammad NASIRI, Shahram Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms |
title | Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms |
title_full | Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms |
title_fullStr | Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms |
title_full_unstemmed | Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms |
title_short | Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms |
title_sort | approach to patients with neurometabolic diseases who show characteristic signs and symptoms |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468080/ https://www.ncbi.nlm.nih.gov/pubmed/32952579 |
work_keys_str_mv | AT karimzadehparvaneh approachtopatientswithneurometabolicdiseaseswhoshowcharacteristicsignsandsymptoms AT ghofranimohammad approachtopatientswithneurometabolicdiseaseswhoshowcharacteristicsignsandsymptoms AT nasirishahram approachtopatientswithneurometabolicdiseaseswhoshowcharacteristicsignsandsymptoms |